99% Savings - Buy Just @1 Rs X
Ramilace is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Ramilace safe for pregnant women?
Ramilace shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of Ramilace safe during breastfeeding?
Side effects of Ramilace on breastfeeding women are very mild.
What is the effect of Ramilace on the Kidneys?
Ramilace has very mild side effects on the kidneys.
What is the effect of Ramilace on the Liver?
Ramilace may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Ramilace on the Heart?
Ramilace has very mild side effects on the heart.
Ramilace should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Ramilace unless your doctor advises you to do so -
Is this Ramilace habit forming or addictive?
Forming a habit of Ramilace has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Ramilace, you should not drive or work on any heavy machine, as Ramilace can make you drowsy.
Is it safe?
Yes, but consume Ramilace only on doctor's advice.
Is it able to treat mental disorders?
No, Ramilace cannot treat any kind of mental disorder.
Interaction between Food and Ramilace
Eating certain foods may increase the time it takes Ramilace to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Ramilace
Due to lack of research, there is no information about the side effects of taking Ramilace with alcohol.
Yes, Ramilace has been reported to cause constipation in patients who are taking it but it occurs very rarely. However, if you are experiencing severe constipation after taking this drug then inform your doctor and take precautionary methods such as eating fibrous foods to avoid constipation.
Rarely, Ramilace causes arrhythmia (Irregular heartbeat). However, if you experience any fluctuation in heart rate after consuming this drug, please inform a doctor and follow his/her instructions.
Ramilace is an ACE inhibitor. It works by decreasing the production of a substance that raises the blood pressure, it also dilates and relaxes the blood vessels which make it easier for the heart to pump blood around the body. Hence in this way, Ramilace reduces blood pressure as well as another heart-related disease.
Ramilace is the brand name of ramipril. It is a prescription drug that belongs to the class of medicine called ACE inhibitors (Angiotensin Converting Enzyme Inhibitors). It is available in the form of a tablet and capsule. It is used in the treatment of high blood pressure ( high BP), reduces the risk of heart attack or stroke, and heart failure. It is also used to treat people with diabetes who have developed kidney problems.
No, Ramilace does not cause diabetes. It has not been reported to cause diabetes. However, Ramilace might increase your blood sugar levels slightly, health people can tolerate it easily while the diabetic patients might have some problem. So, if you have diabetes keep a check on your blood sugar levels and in case of a sudden spike inform your doctor and take medicines accordingly.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Altace (ramipril)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 163-169
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 503